E-cigarettes ineffective for cessation and prevention; consumer advocacy group contends Walgreens pharmacy violates HIPAA;

News From Around the Web

> E-cigarettes are ineffective for smoking cessation and prevention, according to a new longitudinal analysis of a national sample of smokers in the U.S. published in JAMA Internal Medicine. Study

> The Walgreens pharmacy model violates HIPAA, a complaint from a consumer advocacy group says. The complaint alleges the business model causes "illegal risks to public health and endangers the privacy of patient information," according to a statement, the Tampa Business Journal reports. Article

> Doctors have responded to the interview with former National Coordinator Blumenthal in The Atlantic--check out their varying responses here

Mobile Healthcare News

> The proliferation and increasing use of mobile healthcare apps requires an unbiased review and certification process, argues a paper published Monday in the Journal of the American Medical Association. Article

> University of Cambridge researchers have developed a new smartphone app that promises to enhance the accuracy of colorimetric tests for diabetes, kidney disease and urinary tract infections. The Colorimetrix software also allows test-strip results to be shared real-time with medical professionals for quicker diagnosis and treatment, according to an announcement. Article

Health Provider News

> In a turbulent time of hospital consolidations, higher than ever CEO turnover, proposed limits on executive pay and declining Medicare reimbursements, hospitals and healthcare systems have their work cut out for them when negotiating CEO compensation. Article

And Finally... Dazed and confused. Woof. Article

Suggested Articles

The potential long-term impacts of COVID-19 on how Medicare Advantage's star ratings are calculated remain unclear, experts say.

There is a potential legal skirmish brewing between two of the largest telehealth companies over patent claims.

Buoyed by strong demand for its stock, GoodRx raised $1.1 billion in its IPO after pricing its deal well above its expected price range.